RCUS announcements Arcus Biosciences, Inc. announcements and dividends declared NYSE
Arcus Biosciences, Inc. Complete list of announcements declared & dividend announcements by Arcus Biosciences, Inc. RCUS
Arcus Biosciences, Inc. RCUS listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Arcus Biosciences, Inc. RCUS
Arcus Biosciences' Quemliclustat Gets Orphan Drug Status For Pancreatic Cancer
(RTTNews) - Arcus Biosciences, Inc. (RCUS) Thursday said that its quemliclustat was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. Orphan drug designation qualifies for several benef
Announcement as on 10 July 2025
B of A Securities Maintains Arcus Biosciences (RCUS) Neutral Recommendation
Fintel reports that on September 5, 2023, B of A Securities maintained coverage of Arcus Biosciences (NYSE:RCUS) with a Neutral recommendation.
Announcement as on 06 September 2023
Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug
Shares of Arcus Biosciences Inc. were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that it's developing with Gilead Sciences Inc. improved progression-free
Announcement as on 20 December 2022
Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for 5 million
Shares of Arcus Biosciences Inc. rocketed 21% in premarket trading Thursday, after Gilead Sciences Inc. said it's exercising options to three programs in the company's clinical-stage portfolio for payments of 5 million. The programs in question includ
Announcement as on 18 November 2021
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of .11 per share versus the Zacks Consensus Estimate of a loss of .13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 08 November 2021
Announcements by Arcus Biosciences, Inc. first page | Next page |
RCUS Arcus Biosciences, Inc. current price & indicator signals
Recent prices of RCUS Arcus Biosciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 08 Mon Dec 2025 | 25.80 | 25.43 to 26.25 | 1.38% | 0.65 times |
| 05 Fri Dec 2025 | 25.45 | 24.67 to 25.80 | 0.75% | 0.63 times |
| 04 Thu Dec 2025 | 25.26 | 24.32 to 25.87 | -1.44% | 0.94 times |
| 03 Wed Dec 2025 | 25.63 | 25.33 to 26.40 | 0.79% | 1.08 times |
| 02 Tue Dec 2025 | 25.43 | 24.77 to 26.35 | -2.57% | 1.35 times |
| 01 Mon Dec 2025 | 26.10 | 25.11 to 26.26 | 0% | 1.3 times |
| 28 Fri Nov 2025 | 26.10 | 25.62 to 26.32 | 2.11% | 0.34 times |
| 26 Wed Nov 2025 | 25.56 | 24.00 to 26.03 | 5.27% | 0.98 times |
| 25 Tue Nov 2025 | 24.28 | 22.85 to 24.95 | 4.66% | 1.7 times |
| 24 Mon Nov 2025 | 23.20 | 21.90 to 23.38 | 5.22% | 0.66 times |
| 21 Fri Nov 2025 | 22.05 | 20.82 to 22.49 | 3.86% | 1.01 times |
| 20 Thu Nov 2025 | 21.23 | 20.50 to 21.55 | 5% | 1.06 times |
Videos related to: RCUS announcements Arcus Biosciences, Inc. announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


